Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is als... YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China. Mostrar mais
Pergunte à ADVFN Intelligence (IA)
| Período | Var | Var % | Abe | Máx. | Mín. | Vol Méd. | VWAP diário | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0625 | 7.93650793651 | 0.7875 | 0.85 | 0.71 | 127083 | 0.81290398 | CS |
| 4 | 0.4335 | 104.081632653 | 0.4165 | 0.85 | 0.4165 | 85861 | 0.73078919 | CS |
| 12 | 0.3332 | 64.4736842105 | 0.5168 | 0.85 | 0.3613 | 43475 | 0.63012734 | CS |
| 26 | -0.24 | -22.0183486239 | 1.09 | 1.12 | 0.3613 | 46335 | 0.68821842 | CS |
| 52 | -0.24 | -22.0183486239 | 1.09 | 1.12 | 0.3613 | 46335 | 0.68821842 | CS |
| 156 | -0.24 | -22.0183486239 | 1.09 | 1.12 | 0.3613 | 46335 | 0.68821842 | CS |
| 260 | -0.24 | -22.0183486239 | 1.09 | 1.12 | 0.3613 | 46335 | 0.68821842 | CS |
Suporte: (11) 4950 5808 | suporte@advfn.com.br
Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições
Recursos principais
Premium
